Clinical Trial Update: Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating AMT2003 versus placebo in advanced cancer patients conducted by Auron Healthcare GmbH has been terminated. The trial targe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Genital Cancer
• Gastrointestinal Cancer
• Prostate Cancer

Drugs mentioned

• AMT2003

Snippet

Sponsor: Auron Healthcare GmbH | Conditions: Gastrointestinal Cancer, Prostate Cancer | Phase 2, Phase 3 | Status: TERMINATED